Chrisiida Tsimplouli

A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer

Buse Cevatemre, Merve Erkısa, Nazlıhan Aztopal et al. · Pharmacological Research · 2017 · 85 citations · Full text

Medicine, Oncology, Pharmacology +11

Labd-14-ene-8,13-diol (sclareol) induces cell cycle arrest and apoptosis in human breast cancer cells and enhances the activity of anticancer drugs

Konstantinos Dimas, M. Papadaki, Chrisiida Tsimplouli et al. · Biomedicine & Pharmacotherapy · 2006 · 69 citations

Medicine, Oncology, Pharmacology +13

New chimeric advanced Drug Delivery nano Systems (chi-aDDnSs) as doxorubicin carriers

Κonstantinos Gardikis, Chrisiida Tsimplouli, Konstantinos Dimas et al. · International Journal of Pharmaceutics · 2010 · 57 citations

Pharmacy, Pharmaceutics, Pharmacology +12

The labdane diterpene sclareol (labd-14-ene-8, 13-diol) induces apoptosis in human tumor cell lines and suppression of tumor growth in vivo via a p53-independent mechanism of action

Louisa G. Mahaira, Chrisiida Tsimplouli, Nikos Sakellaridis et al. · European Journal of Pharmacology · 2011 · 43 citations

Medicine, Cancer Biology, Oncology +11

A New Chimeric Drug Delivery Nano System (chi-aDDnS) Composed of PAMAM G 3.5 Dendrimer and Liposomes as Doxorubicin's Carrier. <I>In Vitro</I> Pharmacological Studies

Κonstantinos Gardikis, Dimitrios Fessas, Marco Signorelli et al. · Journal of Nanoscience and Nanotechnology · 2011 · 28 citations

Pharmacy, Pharmaceutics, Pharmacology +17